TS-142 clinical trials
Also written TS-142.
How each study uses TS-142 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
15 studies that test it; most in 2021 (4)
| Year | Studies |
|---|---|
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 3 |
| 2023 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 15 · Other 0
Taisho Pharmaceutical Co., Ltd. (14) · Taisho Pharmaceutical R&D Inc. (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses TS-142 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 15
- Early Phase 2 Clinical Study of TS-142 in Patients with Insomnia DisorderCompletedPhase 2Taisho Pharmaceutical Co., Ltd.NCT04573725Written as TS-142
- A Pharmacokinetic Study of TS-142 in Patients with Hepatic ImpairmentCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05624944Written as TS-142 5 mg
- A QT/QTc Evaluation Study of TS-142 in Healthy Adult SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04873323Written as TS-142
- Late Phase II Study of TS-142 in Patients with InsomniaCompletedPhase 2Taisho Pharmaceutical Co., Ltd.NCT04469023Written as TS-142
- A Study to Investigate the Next-day Residual Effects of TS-142 in Healthy Elderly SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05819710Written as TS-142
- Drug-drug Interaction Study with TS-142 in Healthy Adult Subjects (concomitant Administration of Itraconazole)CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04557163Written as TS-142
- Phase III Study of TS-142 in Patients with InsomniaCompletedPhase 3Taisho Pharmaceutical Co., Ltd.NCT05453136Written as TS-142 5 mg
- A Phase I Study of TS-142 in Healthy Participants (Repeated Doses)CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04169906Written as TS-142, 10 mg
- A Study to Evaluate Next Day Effects of TS-142 on Driving Performance in Healthy SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04696952Written as TS-142
- Long-Term Study of TS-142 in Patients with InsomniaCompletedPhase 3Taisho Pharmaceutical Co., Ltd.NCT05461352Written as TS-142 5 mg
- A Food Effect Study of TS-142 in Healthy SubjectsCompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT05707897Written as TS-142 10 mg
- A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04746105Written as TS-142
- Mass Balance Study of TS-142 in Healthy Adult Subjects.CompletedPhase 1Taisho Pharmaceutical Co., Ltd.NCT04814771Written as [14C] TS-142
- Safety, Pharmacokinetic, and Pharmacodynamic Study of TS-142 in Healthy SubjectsCompletedPhase 2Taisho Pharmaceutical Co., Ltd.NCT04087707Written as Step 1: TS-142
- A Single Ascending and Repeated Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TS-142 in Healthy ParticipantsCompletedPhase 1Taisho Pharmaceutical R&D Inc.NCT04464239Written as TS-142